CompletedNot Applicable

Intervention for Improving Psychological Distress in Dialysis

United Kingdom25 participantsStarted 2015-02

Plain-language summary

To explore whether it is feasible to recruit and retain haemodialysis patients into a randomised controlled trial of online cognitive-behavioural therapy to manage distress

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Aged 18 years or over and receive hospital haemodialysis three-times weekly
✓. Presence of mild to moderately severe depressive symptoms (based on PHQ-9 scores of 5 to 19 in range; a self-report measure of depression) and/or presence of mild to moderate anxiety symptoms (based on GAD-7 scores of 5-14)
✓. Speak English sufficiently well to engage with screening tools
✓. Have a basic understanding of how to use the Internet and an email address
✓. Have a minimum dialysis vintage of ≥3 months (electronic patient record)

Exclusion criteria

✕. Hospitalised at the time of assessment or within 1 month prior to the assessment
✕. Currently receiving active treatment for depression and/or anxiety. We consider active treatment to be any current psychological treatments (talking therapies) or receipt of a new anti-depressant and/or anti-anxiety medication. A medication is considered new if it is commenced three months prior to the completion of the depression and anxiety screening questionnaire
✕. Severe mental health disorders, for example, psychosis, bi-polar disorder
✕. Active suicidal thoughts-any participant that scores greater than one on the depression PHQ-9 item "Thoughts that you would be better off dead, or of hurting yourself" will be excluded from the study.
✕. Evidence of addiction to alcohol or drugs

What they're measuring

Consent to psychological screen rate using self-report measures of depression (PHQ-9) and anxiety (GAD-7)

Timeframe: Baseline recruitment/screening

Trial details

NCT IDNCT02352870

SponsorKing's College London

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2016-06

View on ClinicalTrials.gov More Kidney Failure, Chronic trials